| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/16/2023 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 30k | $12.17 | $365.1k | | 01/16/2023 |
| 05/26/2022 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 20k | $8.31 | $166.2k | | 05/26/2022 |
| 02/08/2022 | Arcellx, Inc. | | Conversion | Common Stock | 2.1M | $0.00 | $0 | See footnote | 02/08/2022 |
| 02/08/2022 | Arcellx, Inc. | | Conversion | Series B-1 Preferred Stock | 1.2M | $0.00 | $0 | See footnote | 02/08/2022 |
| 02/08/2022 | Arcellx, Inc. | | Conversion | Series B-2 Preferred Stock | 931.2k | $0.00 | $0 | See footnote | 02/08/2022 |
| 05/27/2021 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 18k | $35.23 | $634.1k | | 05/27/2021 |
| 05/11/2021 | Neoleukin Therapeutics, Inc. | AQXP | Grant | Stock Option (Right to Buy) | 25k | $11.40 | $285k | | 05/11/2021 |
| 05/28/2020 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 15k | $16.54 | $248.1k | | 05/28/2020 |
| 05/05/2020 | Neoleukin Therapeutics, Inc. | AQXP | Grant | Stock Option (Right to Buy) | 25k | $12.84 | $321k | | 05/05/2020 |
| 10/10/2019 | Neoleukin Therapeutics, Inc. | AQXP | Grant | Stock Option (right to buy) | 22k | $2.82 | $62k | | 10/10/2019 |
| 09/01/2019 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Payment of Exercise | Common Stock | 7k | $5.43 | $38.1k | | 09/01/2019 |
| 06/10/2019 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Grant | Stock Option (right to buy) | 15k | $6.09 | $91.4k | | 06/10/2019 |
| 06/07/2019 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 12k | $11.80 | $141.6k | | 06/07/2019 |
| 02/26/2019 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Payment of Exercise | Common Stock | 926 | $11.95 | $11.1k | | 02/26/2019 |
| 02/25/2019 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Grant | Common Stock | 1000 | $0.00 | $0 | | 02/25/2019 |
| 02/25/2019 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Grant | Employee Stock Option (right to buy) | 6.4k | $11.97 | $76.6k | | 02/25/2019 |
| 02/05/2019 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Payment of Exercise | Common Stock | 3.1k | $11.43 | $35.9k | | 02/05/2019 |
| 11/05/2018 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Exercise | Employee Stock Option (right to buy) | 91.2k | $4.56 | $415.9k | | 11/05/2018 |
| 09/01/2018 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Payment of Exercise | Common Stock | 7k | $14.00 | $98.3k | | 09/01/2018 |
| 05/29/2018 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 12k | $6.98 | $83.8k | | 05/29/2018 |
| 02/26/2018 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Grant | Common Stock | 5k | $0.00 | $0 | | 02/26/2018 |
| 02/26/2018 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Grant | Employee Stock Option (right to buy) | 30k | $18.69 | $560.7k | | 02/26/2018 |
| 02/05/2018 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Payment of Exercise | Common Stock | 3.1k | $18.42 | $57.8k | | 02/05/2018 |
| 09/01/2017 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Payment of Exercise | Common Stock | 7.8k | $34.34 | $268.8k | | 09/01/2017 |
| 06/15/2017 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 24k | $10.84 | $260.2k | | 06/15/2017 |
| 03/01/2017 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Payment of Exercise | Common Stock | 34.5k | $44.77 | $1.5M | | 03/01/2017 |
| 02/07/2017 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Grant | Common Stock | 16.9k | $0.00 | $0 | | 02/07/2017 |
| 02/07/2017 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Grant | Employee Stock Option (right to buy) | 101.2k | $45.38 | $4.6M | | 02/07/2017 |
| 01/03/2017 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Payment of Exercise | Common Stock | 5.1k | $48.60 | $246.2k | | 01/03/2017 |
| 12/23/2016 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Exercise | Employee Stock Option (right to buy) | 29.8k | $5.54 | $165.2k | | 12/23/2016 |
| 12/23/2016 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Sale | Common Stock | 29.7k | $50.49 | $1.5M | | 12/23/2016 |
| 12/23/2016 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Sale | Common Stock | 300 | $51.02 | $15.3k | | 12/23/2016 |
| 12/23/2016 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Exercise | Employee Stock Option (right to buy) | 155 | $4.56 | $706.8 | | 12/23/2016 |
| 12/23/2016 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Exercise | Employee Stock Option (right to buy) | 19 | $6.89 | $130.9 | | 12/23/2016 |
| 12/23/2016 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Exercise | Employee Stock Option (right to buy) | 10 | $8.49 | $84.9 | | 12/23/2016 |
|